Literature DB >> 22744911

Motivations for genetic testing for lung cancer risk among young smokers.

Suzanne C O'Neill1, Isaac M Lipkus, Saskia C Sanderson, James Shepperd, Sharron Docherty, Colleen M McBride.   

Abstract

OBJECTIVE: To examine why young people might want to undergo genetic susceptibility testing for lung cancer despite knowing that tested gene variants are associated with small increases in disease risk.
METHODS: The authors used a mixed-method approach to evaluate motives for and against genetic testing and the association between these motivations and testing intentions in 128 college students who smoke.
RESULTS: Exploratory factor analysis yielded four reliable factors: Test Scepticism, Test Optimism, Knowledge Enhancement and Smoking Optimism. Test Optimism and Knowledge Enhancement correlated positively with intentions to test in bivariate and multivariate analyses (ps<0.001). Test Scepticism correlated negatively with testing intentions in multivariate analyses (p<0.05). Open-ended questions assessing testing motivations generally replicated themes of the quantitative survey.
CONCLUSION: In addition to learning about health risks, young people may be motivated to seek genetic testing for reasons, such as gaining knowledge about new genetic technologies more broadly.

Entities:  

Keywords:  GSTM1; Motivations; addiction; cessation; genetic testing; prevention; primary prevention

Mesh:

Year:  2012        PMID: 22744911      PMCID: PMC3586780          DOI: 10.1136/tobaccocontrol-2011-050306

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  33 in total

1.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

Review 2.  Effectiveness of testing for genetic susceptibility to smoking-related diseases on smoking cessation outcomes: a systematic review and meta-analysis.

Authors:  Chris Smerecnik; Janaica E J Grispen; Marieke Quaak
Journal:  Tob Control       Date:  2011-09-26       Impact factor: 7.552

3.  Dispositional motivations and genetic risk feedback.

Authors:  J Lee Westmaas; Patricia Butler Woicik
Journal:  Addict Behav       Date:  2005-09       Impact factor: 3.913

4.  Potential for genetics to promote public health: genetics research on smoking suggests caution about expectations.

Authors:  Chris Carlsten; Wylie Burke
Journal:  JAMA       Date:  2006-11-22       Impact factor: 56.272

Review 5.  Increasing the demand for and use of effective smoking-cessation treatments reaping the full health benefits of tobacco-control science and policy gains--in our lifetime.

Authors:  C Tracy Orleans
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

6.  Young smokers' views of genetic susceptibility testing for lung cancer risk: minding unintended consequences.

Authors:  Sharron L Docherty; Colleen M McBride; Saskia C Sanderson; Suzanne C O'Neill; James A Shepperd; Isaac M Lipkus
Journal:  J Community Genet       Date:  2011-09

7.  A meta-analysis of computer-tailored interventions for health behavior change.

Authors:  Paul Krebs; James O Prochaska; Joseph S Rossi
Journal:  Prev Med       Date:  2010-06-15       Impact factor: 4.018

8.  The convergence of lung cancer rates between blacks and whites under the age of 40, United States.

Authors:  Ahmedin Jemal; Melissa M Center; Elizabeth Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

9.  On Quantitizing.

Authors:  Margarete Sandelowski; Corrine I Voils; George Knafl
Journal:  J Mix Methods Res       Date:  2009-07-01

10.  The global burden of cancer: priorities for prevention.

Authors:  Michael J Thun; John Oliver DeLancey; Melissa M Center; Ahmedin Jemal; Elizabeth M Ward
Journal:  Carcinogenesis       Date:  2009-11-24       Impact factor: 4.944

View more
  8 in total

1.  Predicting Avoidance of Skin Damage Feedback Among College Students.

Authors:  Laura A Dwyer; James A Shepperd; Michelle L Stock
Journal:  Ann Behav Med       Date:  2015-10

2.  Introducing genetic testing for cardiovascular disease in primary care: a qualitative study.

Authors:  Jo B Middlemass; Momina F Yazdani; Joe Kai; Penelope J Standen; Nadeem Qureshi
Journal:  Br J Gen Pract       Date:  2014-05       Impact factor: 5.386

3.  Young smokers' interpretations of the estimated lung cancer risk associated with a common genetic variant of low penetrance.

Authors:  S C Sanderson; C M McBride; S C O'Neill; S Docherty; J Shepperd; I M Lipkus
Journal:  Public Health Genomics       Date:  2014-02-19       Impact factor: 2.000

4.  Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age.

Authors:  Joann Seo; Jennifer Ivanovich; Melody S Goodman; Barbara B Biesecker; Kimberly A Kaphingst
Journal:  J Genet Couns       Date:  2016-08-20       Impact factor: 2.537

5.  In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community.

Authors:  Jessica L Bourdon; Amelia Dorsey; Maia Zalik; Amanda Pietka; Patricia Salyer; Michael J Bray; Laura J Bierut; Alex T Ramsey
Journal:  BMC Med Genomics       Date:  2021-05-26       Impact factor: 3.063

6.  Smokers' beliefs about the tobacco control potential of "a gene for smoking": a focus group study.

Authors:  Erika A Waters; Linda Ball; Kimberly Carter; Sarah Gehlert
Journal:  BMC Public Health       Date:  2014-11-25       Impact factor: 3.295

Review 7.  Mixed methods research in tobacco control with youth and young adults: A methodological review of current strategies.

Authors:  Craig S Fryer; Elizabeth L Seaman; Rachael S Clark; Vicki L Plano Clark
Journal:  PLoS One       Date:  2017-08-25       Impact factor: 3.240

8.  Predictors of patient uptake of colorectal cancer gene environment risk assessment.

Authors:  Michael J Hall; Sharon L Manne; Ronald E Myers; Eileen M Keenan; Andrew M Balshem; David S Weinberg
Journal:  Genome Med       Date:  2012-11-29       Impact factor: 11.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.